Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2012-04-11 Capital/Financing Update
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
Thrombogenics_-_604_report_-_EN.PDF
Capital/Financing Update Classification · 95% confidence The document is explicitly titled "SPECIAL REPORT OF THE BOARD OF DIRECTORS IN ACCORDANCE WITH ARTICLE 604 OF THE BELGIAN COMPANY CODE". It details proposals regarding the renewal and extension of the board of directors' power to increase the company's share capital (authorized capital), including provisions for takeover bids and exclusion of preferential subscription rights. This content directly relates to corporate governance, capital structure changes, and specific legal requirements for shareholder meetings concerning capital authorization. While it discusses capital changes (suggesting CAP or SHA), the document itself is a formal report prepared for a shareholders' meeting to approve these powers, which aligns closely with governance or capital structure documentation presented to shareholders. Given the focus on the legal report structure and the proposed powers related to capital, it is best classified as a document related to capital structure changes presented formally, which falls under Capital/Financing Update (CAP) or potentially Governance Information (CGR). However, since the core subject is granting powers for future capital increases and financing mechanisms, 'CAP' is a strong fit. Alternatively, because it is a formal report mandated by the Company Code (Article 604 BCC) detailing board proposals for shareholder approval, it also strongly resembles a governance document. Since the proposals are fundamentally about the mechanism of capital raising, I will select CAP, but acknowledge the strong governance aspect. Given the context of Belgian corporate law reporting on authorized capital, this is a specific type of financing/capital structure document.
2012-04-11 English
Thrombogenics_-_604_verslag_-_NL.PDF
Governance Information Classification · 95% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 604 VAN HET WETBOEK VAN VENNOOTSCHAPPEN" (Special Report of the Board of Directors pursuant to Article 604 of the Companies Act). This report details proposals to the general meeting regarding the renewal and extension of the authorized capital ('toegestaan kapitaal') and the authority to increase capital, including provisions for takeover bids and exclusion of pre-emptive rights. This type of detailed report prepared by the Board for shareholders regarding proposed statutory changes and capital structure decisions, often preceding a general meeting, strongly aligns with documents related to corporate governance and shareholder decisions. Since it is a detailed report explaining proposed actions to be voted upon, it is not a simple announcement (RPA/RNS) but a substantive document. Given the focus on board authority, capital structure, and preparation for a general meeting, it fits best under Governance Information (CGR) or potentially a specialized report related to capital changes (CAP). However, the structure and content—a formal 'Special Report' detailing the rationale for proposed resolutions concerning capital authorization and statutory changes—is characteristic of governance documentation presented to shareholders for approval. In the context of the provided definitions, 'Governance Information (CGR)' is the most appropriate fit for a detailed report on board structure/rules/practices, especially when dealing with statutory powers like authorized capital, which is a core governance mechanism. It is not a standard 10-K, AR, or ER. It is a formal report explaining proposed changes to the company's foundational powers.
2012-04-11 Dutch
BR-6676157-v6-Volmacht_algemene_vergadering1.pdf
AGM Information Classification · 98% confidence The document is titled 'VOLMACHT' (Proxy/Power of Attorney) and explicitly details the process for a shareholder to be represented at the 'jaarvergadering en/of de buitengewone algemene vergadering' (Annual General Meeting and/or Extraordinary General Meeting). It contains a proxy form, specifies deadlines for submission (e.g., 'uiterlijk op 26 april 2012'), and lists the detailed agenda items for both the Extraordinary Meeting (focusing on capital authorization and statutory changes) and the Annual Meeting (reviewing the annual report for the year ended December 31, 2011). The presence of a proxy form and the focus on shareholder representation for voting on meeting agendas strongly indicates this document is related to the Annual General Meeting process. This aligns best with the AGM Information (AGM-R) category, which covers presentations and materials shared during the AGM, including the necessary forms for participation.
2012-04-11 Dutch
Jaarrekening-2011-final2.pdf
Annual Report Classification · 100% confidence The document is a 'Jaarrekening' (Annual Accounts) for the company ThromboGenics, covering the fiscal year 2011. It includes formal registration details, board member information, and is structured as a statutory financial filing required by Belgian law. Since it represents the official annual financial reporting for the company, it is classified as an Annual Report (10-K). FY 2011
2012-04-11 Dutch
Bijzonder-Verslag-RvB_NL.pdf
Governance Information Classification · 95% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 604 VAN HET WETBOEK VAN VENNOOTSCHAPPEN" (Special Report of the Board of Directors pursuant to Article 604 of the Companies Act). This report details proposals to the general meeting regarding the renewal and extension of the authorized capital ('toegestaan kapitaal') and the authority to increase capital, including provisions for takeover bids and exclusion of pre-emptive rights. This type of detailed report prepared by the Board for shareholders regarding proposed statutory changes and capital structure decisions, often preceding a general meeting, strongly aligns with documents related to corporate governance and shareholder decisions. Since it is a detailed report explaining proposed actions to be voted upon, it is not a simple announcement (RPA/RNS) but a substantive document. Given the focus on board authority, capital structure, and preparation for a general meeting, it fits best under Governance Information (CGR) or potentially a specialized report related to capital changes (CAP). However, the structure and content—a formal 'Special Report' detailing the rationale for proposed resolutions concerning capital authorization and statutory changes—is characteristic of governance documentation presented to shareholders for approval. In the context of the provided definitions, 'Governance Information (CGR)' is the most appropriate fit for a detailed report on board structure/rules/practices, especially when dealing with statutory powers like authorized capital, which is a core governance mechanism. It is not a standard 10-K, AR, or ER. It is a formal report explaining proposed changes to the company's foundational powers.
2012-04-11 Dutch
R-ThromboGenics-CR-31122011-NL1.pdf
Audit Report / Information Classification · 99% confidence The document is titled "Verslag van de commissaris aan de algemene vergadering der aandeelhouders over de jaarrekening over het boekjaar afgesloten op 31 december 2011" (Report of the commissioner to the general meeting of shareholders on the annual accounts for the financial year ended December 31, 2011). This explicitly indicates it is the formal report issued by an external auditor (Commissaris/BDO) concerning the annual financial statements. While it is addressed to the AGM, its core content is the auditor's opinion on the annual accounts. This aligns perfectly with the definition of an Audit Report/Information (AR), which covers standalone audit reports and applied accounting principles, distinguishing it from the full Annual Report (10-K) or the AGM presentation materials (AGM-R). The document contains the auditor's opinion ('Verklaring over de jaarrekening zonder voorbehoud') for the fiscal year ending 2011. FY 2011
2012-04-11 Dutch

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.